TGFB1 and systemic sclerosis: Additionally, EGCG can counteract TGFβ-induced ROS in human dermal fibroblasts from healthy controls, SSc patients, and in a dermal fibroblast cell line, indicating its potential effectiveness as an antioxidant to reduce oxidant stress in the disease scleroderma [114].